Biolife Sciences (BLFE)
OTHER OTC:BLFE
US Market
Holding BLFE?
Track your performance easily

Biolife Sciences (BLFE) Income Statement

55 Followers

Biolife Sciences Income Statement

Last quarter (Q ), Biolife Sciences's total revenue was $―, a decrease of ― from the same quarter last year. In Q, Biolife Sciences's net income was $-51.11K. See Biolife Sciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 21Dec 20Dec 19Dec 18Dec 17
Total Revenue
------
Cost of Revenue
---$ 82.00$ 176.00$ 176.00
Gross Profit
---$ -82.00$ -176.00$ -176.00
Operating Expense
$ -291.37K$ 63.00K$ 58.32K$ 75.43K$ 74.68K$ 257.24K
Operating Income
$ -342.33K$ -63.00K$ -58.32K$ -75.52K$ -74.85K$ -257.42K
Net Non Operating Interest Income Expense
------
Other Income Expense
$ -280.94K$ -1.74K$ 21.01K$ -2.08M$ -36.19K$ 598.86K
Pretax Income
$ -624.01K$ -64.74K$ -37.31K$ -2.15M$ -111.04K$ 341.45K
Tax Provision
------
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -624.01K$ -64.74K$ -37.31K$ -2.15M$ -111.04K$ 341.45K
Basic EPS
$ -0.06$ -1.00$ -1.00$ -0.40-$ 0.10
Diluted EPS
$ -0.06$ -1.00$ -1.00$ -0.40-$ 0.10
Basic Average Shares
$ 43.22M$ 52.66K$ 52.66K$ 5.27M$ 5.27M$ 5.24M
Diluted Average Shares
$ 43.22M$ 52.66K$ 52.66K$ 5.27M$ 5.27M$ 5.24M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ -342.33K$ -63.00K$ -58.32K$ -75.52K$ -74.85K$ -257.42K
Net Income From Continuing And Discontinued Operation
$ -624.01K$ -64.74K$ -37.31K$ -2.15M$ -111.04K$ 341.45K
Normalized Income
$ -624.01K$ -64.74K$ -37.31K$ -2.15M$ -111.04K$ 341.45K
Interest Expense
------
EBIT
$ -624.01K$ -64.74K$ -37.31K$ -2.15M$ -111.04K$ 341.45K
EBITDA
------
Currency in USD

Biolife Sciences Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis